Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine

Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine

US Patent 11090326 · Granted Aug 17, 2021

Estimated economic value: $2,378,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating ulcerative colitis2025
Methods and compositions for treating ulcerative colitis2025
Methods for treating, ameliorating or preventing infections using drug and vacci2025
Compositions for fecal floral transplantation and methods for making and using t2024
Pharmaceutical compositions comprising lonafarnib and ritonavir2024
All-in-one fixed-dose combination for treating Helicobacter pylori infection2024
Compositions and methods for treating epilepsy and related disorders2024
Compositions for fecal floral transplantation and methods for making and using t2024
Compositions for fecal floral transplantation and methods for making and using t2024
Methods for treating, ameliorating or preventing infections using drug and vacci2024
Compositions for fecal floral transplantation and methods for making and using t2023
Compositions and methods for treating, ameliorating and preventing H. pylori in2023